Clinical Trials Browser

Phase 2 × Terminated × Interleukin-12 Subunit p35 × Clear all

NCT01307618 2016-10-24

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Phase 2 Terminated

10 enrolled 8 charts

Melanoma